The Latest
-
Q&A
Olympus’ Keith Boettiger on robotic GI surgery push
Keith Boettiger, head of Olympus’ gastrointestinal solutions division, delves into the endoscopy leader’s endoluminal robotics strategy.
-
J&J, Medtronic back CereVasc’s $85M funding round
CereVasc is developing a minimally invasive treatment for the buildup of fluid in the brain.
-
Dexcom buys Nutrisense; Insulet rolls out patch pump update
In the lead-up to the American Diabetes Association’s Scientific Sessions, Dexcom announced an acquisition and Insulet improved the software for its latest patch pump.
-
More Americans own wearables, connected health devices: survey
Many adults are sharing device data with their providers too. But users are typically healthier and wealthier, suggesting people who could benefit the most from monitoring are less likely to adopt the tools, according to Rock Health.
-
Medtronic seeks clearance for Hugo surgical robot in more indications
Securing 510(k) authorization would position Medtronic to compete with Intuitive in major robotic surgery markets.
-
Edwards gets FDA approval for surgical tricuspid valve
Built specifically to mimic the native tricuspid anatomy, the implant is intended to address an unmet patient need.
-
Medtronic boosts revenue by nearly double digits in Q4
Strength in cardiac ablation solutions, where the company picked up market share, helped Medtronic post its best annual revenue growth rate in a decade.
-
MiniMed expands Abbott partnership to add dual glucose-ketone sensor
In its first earnings call, the newly independent diabetes tech firm said it was transforming its product portfolio, with plans that include a patch pump and an algorithm that doesn’t require meal announcements.
-
At ASCO, Grail points to positive signals in MCED data
Grail executives were upbeat on study results for the Galleri multi-cancer early detection test, while ASCO said more evidence is needed before it is incorporated into screening guidelines.
-
Trump further tweaks steel, aluminum, copper tariffs
A greater range of industrial and agricultural equipment made with the metals will temporarily face a reduced 15% levy starting June 8, per the White House.
-
Resmed completes $340M Noctrix takeover
The buyout gives Resmed control of a noninvasive treatment for restless legs syndrome.
-
Q&A
Natera’s Solomon Moshkevich on how MRD testing pinpoints cancer recurrence
Molecular residual disease testing could one day be as ubiquitous as a CT scan, says Natera’s president of clinical diagnostics.
-
Intuitive elevates Taylor Patton to chief commercial and marketing officer
Patton’s promotion comes as competition in robotic surgery intensifies, and Intuitive looks to expand its global commercial operations to meet anticipated growth.
-
Court overturns Insulet’s $59M trade secret verdict against EOFlow
The U.S. appeals court ruled that Insulet filed the lawsuit too late, considering when it should have learned of the trade secret concerns.
-
California attorney general sues over 23andMe data breach
The attorney general said the civil penalties could add up to “multiple millions” if the suit is successful.
-
J&J recalls Impella heart pumps after patient dies
Johnson & Johnson asked customers to quarantine and return affected products. A spokesperson said J&J conducted quality system audits as part of its integration of Abiomed that resulted in some field actions.
-
Siemens Healthineers, AiM team up; Procept completes study enrollment
Siemens Healthineers’ MRI scanners would guide robotic neurosurgeries performed with AiM’s platform. Elsewhere, Procept finished enrollment in a study of its aquablation treatment in prostate cancer.
-
Ōura to add blood pressure feature following FDA policy change
The new wellness tool would alert users to signs of increasing blood pressure. Ōura is studying a separate feature to flag hypertension that would go through the Food and Drug Administration.
-
Cornerstone earns Europe’s CE mark for surgical robot
CE mark certification comes after Hong Kong-based Cornerstone Robotics raised $200 million in November to accelerate its global expansion.
-
Abbott receives CE mark for dual glucose-ketone sensor
Abbott’s first dual-analyte sensor comes as competitors are working to develop their own versions of the technology.
-
AI in medtech is booming. Track new devices here.
The Food and Drug Administration has authorized more medical devices that incorporate artificial intelligence. Keep track of the latest developments in this database.
Updated May 27, 2026 -
Insulet recalls 7M patch pumps due to leak risk
The recall is Insulet’s second this year related to tears in the device tubing. So far, 24 serious adverse events have been reported.
-
J&J’s DePuy Synthes inks deal to buy orthopedic surgery tech
The acquisition is the latest in a series of agreements between DePuy Synthes and organizations associated with entrepreneur Stéphane Lavallée.
-
Dexcom warns of scrapped glucose sensors being resold
Dexcom has identified two lots of G7 sensors that have been stolen, sold and used by customers.
Updated May 27, 2026 -
Olympus expands in cancer tech with $270M buy of BioProtect
BioProtect’s balloon spacer device separates the prostate from other structures during cancer radiation.